Latest filings (excl ownership)
NT 20-F
Notice of late annual filing (foreign)
1 May 24
6-K
Current report (foreign)
1 May 24
6-K
CENTOGENE Receives Nasdaq Non-Compliance Notice
2 Apr 24
6-K
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
19 Mar 24
6-K
Complete Pre-TCRα Deficiency Found to be Very Rare, Partial Form More Common Than Expected
29 Feb 24
6-K
CENTOGENE Explores Strategic Alternatives
28 Feb 24
6-K
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
28 Feb 24
6-K
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
25 Jan 24
6-K
CENTOGENE Receives French Research Tax Credit Accreditation
24 Jan 24
6-K
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
23 Jan 24
6-K
CENTOGENE Announces Preliminary Full Year 2023 Revenue
18 Jan 24
6-K
CENTOGENE Announces Voting Results of Extraordinary General Meeting
19 Dec 23
6-K
CENTOGENE Announces Changes in Supervisory Board
18 Dec 23
6-K
Current report (foreign)
13 Dec 23
6-K
Current report (foreign)
1 Dec 23
6-K
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
28 Nov 23
6-K
Third Amendment to Loan and Security Agreement
3 Nov 23
6-K
Variation Agreement to Joint Venture Agreement
27 Oct 23
6-K
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
10 Oct 23
6-K
CENTOGENE Announces Changes in Supervisory Board
6 Oct 23
6-K
CENTOGENE Reports First Half 2023 Financial Results
7 Sep 23
6-K
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
1 Sep 23
6-K
CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
31 Aug 23
6-K
CENTOGENE Announces Change in Supervisory Board
18 Aug 23
6-K
Current report (foreign)
14 Jul 23
6-K
Current report (foreign)
12 Jul 23
6-K
CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meeting
30 Jun 23
6-K
Current report (foreign)
27 Jun 23
6-K
CENTOGENE Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
14 Jun 23
6-K
Current report (foreign)
13 Jun 23
6-K
Current report (foreign)
19 May 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
17 May 23
6-K
CENTOGENE Reports Full Year 2022 Financial Results
16 May 23
20-F
2022 FY
Annual report (foreign)
16 May 23
6-K
Second Amendment to Loan and Security Agreement
4 May 23
NT 20-F
Notice of late annual filing (foreign)
28 Apr 23
6-K
CENTOGENE Receives Nasdaq Non-Compliance Notice
28 Apr 23
6-K
CENTOGENE Accelerates Global Genetic Data Interpretation, Launching FilterTool Application as Accessory to CentoCloud® Bioinformatics Pipeline
26 Apr 23
6-K
CENTOGENE Launches NEW CentoGenome®, World’s Most Comprehensive Whole Genome Sequencing Solution for Diagnosis of Rare and Neurodegenerative Diseases
12 Apr 23
6-K
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
11 Apr 23
Latest ownership filings
SC 13D/A
TVM Life Science Innovation I L.P.
11 Mar 22
SC 13D/A
DPE Deutsche Private Equity Gesellschaft mbH
22 Feb 22
SC 13G
PLATINUM INVESTMENT MANAGEMENT LTD
9 Dec 21
144
Notice of proposed sale of securities
12 Jul 21
144
Notice of proposed sale of securities
7 Jul 21
SC 13D/A
DPE Deutsche Private Equity Gesellschaft mbH
12 May 21
SC 13G/A
Rolfs Arndt
16 Feb 21
144
Notice of proposed sale of securities
27 Jan 21
SC 13D/A
DPE Deutsche Private Equity Gesellschaft mbH
5 Nov 20
SC 13D/A
TVM Life Science Innovation I L.P.
3 Nov 20
SC 13D/A
DPE Deutsche Private Equity Gesellschaft mbH
10 Aug 20
SC 13D
Beneficial ownership report
14 Feb 20
SC 13G
Beneficial ownership report
12 Feb 20
SC 13D
Centogene N.V.
14 Jan 20
SC 13D
Centogene N.V.
22 Nov 19